<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

Reimbursement

We believe in an evidence-based approach to care

As a devoted partner, we develop and publish the scientific evidence to support utility of our tests. We work directly with health plans to help ensure patients have access to our services. Our two certified laboratories meet and exceed the standards put forth by the largest regulating bodies.

Many of our tests are covered by Medicare and many private payers. Browse our Managed Care professional resources below to learn more.

VeriStrat®
Proteomic Test

VeriStrat® is blood-based proteomic test that provides predictive and prognostic information for patients with non-small cell lung cancer (NSCLC).

GeneStrat®
Genomic Test

GeneStrat® is a blood-based genomic portfolio that provides guideline-recommended actionable mutations for patients with NSCLC to expedite time to treatment.

Nodify XL2® Proteomic Test​

Nodify XL2® is a blood-based lung nodule test that helps identify patients with a lower risk of malignancy that can be safely monitored with follow-up CT scans, alleviating patient anxiety and avoiding unnecessary invasive diagnostic procedures.

Nodify CDT Proteomic Test​

Nodify CDTis a blood-based lung nodule test that helps identify patients with a higher risk of malignancy that can be prioritized for diagnostic intervention, avoiding delays in lung cancer diagnoses.

We’re Committed to Quality

We operate two world-class, accredited clinical laboratories that support the standards put forth by the largest regulating bodies.

VIEW OUR LIST OF CERTIFICATIONS

Financial Assistance

We understand the financial stresses that health issues can place on patients. That's why we created a financial assistance program for patients with financial responsibility to assist in providing affordable care.

REACH OUT TO OUR CUSTOMER CARE TEAM

Get in touch with our reimbursement team